Efficient Drug Development
TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Our latest developments
23 resultaten, getoond 6 t/m 10
Spatial Mass Spectrometry
Mass spectrometry imaging (MSI) provides tissue-level evidence of drug distribution, mechanism of action and molecular effects, supporting early drug development and disease research.
Atherosclerosis


A preclinical model that captures the full complexity of CKM syndrome


From lab to life in 24 Hours: i-screen demonstrates correlation between laboratory and human gut responses


Testing medicines outside the body: intestinal–liver–kidney model accelerates drug development



